Medical/Pharmaceuticals
Texas A&M University Takes A 12.5% Equity Stake in Volition Veterinary Diagnostics Development LLC
AUSTIN, Texas, Oct. 25, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") announced today that it (through its subsidiaries) has executed binding agreements contemplated by the previously announced Memorandum of Understanding withTexas A&M University ("Texas A&M"), a memb...
2019-10-26 00:00
8879
World first clinical trial commenced in alcohol use disorder
MELBOURNE, Australia, Oct. 24, 2019 /PRNewswire/ -- A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neuroscience and Mental Health. A world-first clinical stu...
2019-10-24 12:01
1310
HCmed introduces Pulmogine in the 2019 ERS Congress
TAIPEI, Oct. 22, 2019 /PRNewswire/ -- HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress. Pulmogine, a mesh nebulizer supported by a customization platform, is able to nebulize...
2019-10-22 16:34
2025
Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
SHANGHAI, Oct. 22, 2019 /PRNewswire/ -- The implementation of the "Healthy China 2030" Planning Outline has ushered in rapid development of China's big health industry, with the industry scale expected to reachRMB8.78 trillion in 2019 andRMB14.09 trillion in 2023, calculated as per the about 12.5...
2019-10-22 12:08
1109
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019
KOFU, Japan and TOKYO, Oct. 21, 2019 /PRNewswire/ -- GN Corporation Co., Ltd., a Japanese firm involved in research and development of technology in regenerative medicine, and Edogawa Evolutionary Laboratory of Science(EELS), a unit ofTokyo's Edogawa Hospital, cosponsored NCRM NICHE 2019 (www.ncr...
2019-10-21 14:00
1180
Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas
AUSTIN, Texas, Oct. 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that Dr. Heather Wilson-Robles DVM, DACVIM, Associate Professor and Dr. Fred and Vola N. Palmer Chair in Comparative Oncology, Texas A&M College of Veterinary Medicine & Biomedical S...
2019-10-18 20:30
10533
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
BEIJING, Oct. 17, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the special committee (the "Special Committee") of the Company's board o...
2019-10-17 20:00
11268
Sirtex Medical appoints Kevin R. Smith as Chief Executive Officer
Interim CEO unanimously chosen to lead global operations in patient-first oncology innovation WOBURN, Mass., Oct. 16, 2019 /PRNewswire/ -- Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, today announced the appointment ofKevin R. Smith as Chief Executive Officer of Sir...
2019-10-16 22:00
1856
Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH
SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- Hepagene Therapeutics, Inc, a clinical stage drug discovery and development company which devotes its efforts towards discovering, developing and delivering innovative medicines that help patients prevail over liver diseases, announced today that it has dos...
2019-10-16 18:00
959
CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland
KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigational Device Exemption (IDE) ...
2019-10-15 20:00
942
Collaborative Medicinal Development Enrolls First Patient In a Randomized, Placebo-Controlled Clinical Trial of CuATSM For The Treatment of Amyotrophic Lateral Sclerosis
MILL VALLEY, Calif. and MELBOURNE, Australia, Oct. 15, 2019 /PRNewswire/ -- Collaborative Medicinal Development, LLC) ("CMD"), a clinical stage biopharmaceutical company with a portfolio of candidates for treatment of neurological and neuropsychiatric diseases, announced today that it enrolled t...
2019-10-15 05:58
1001
WONTECH Receives FDA Clearance for 'HairBoom Air'
SEOUL, South Korea, Oct. 14, 2019 /PRNewswire/ -- WONTECH (Reno Kim, CEO of
WONTECH,www.wtlaser.com
2019-10-14 16:47
1152
STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal
SINGAPORE and MELBOURNE, Australia, Oct. 14, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed a new license deal, enabling it to provide a global advanced sarcoma therapy to patients inAustralia, New Zealand and throughout SE Asia. Under the ...
2019-10-14 14:00
1332
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.
SHANGHAI, Oct. 11, 2019 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that it has successfully completed a first-in-human phase I single ascending dose (SAD) clinical study of KPG-818 conducted inthe United States. This randomized, double-blind, placebo-controlled study evaluated the...
2019-10-11 13:00
1469
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules
SHANGHAI and CAMBRIDGE, Massachusetts and SANKT AUGUSTIN, Germany, Oct. 10, 2019 /PRNewswire/ -- WuXi AppTec Research Service Division and BioSolveIT today launched a new virtual chemical space called GalaXi®. Largely built from WuXi AppTec's library of novel drug-like scaffolds, GalaXi® offers a...
2019-10-11 08:02
7863
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5
SHANGHAI, Oct. 4, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases, today announced that its I...
2019-10-04 13:40
1419
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine
QUEBEC CITY, Oct. 3, 2019 /PRNewswire/ -- Medicago, a biotechnology company and global leader in the development and production of plant-derived vaccines with headquarters inQuebec City, announces today that Health Canada accepted for scientific review its New Drug Submission (NDS) for a plant-ba...
2019-10-03 06:30
1488
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US
ADELAIDE, Australia, Oct. 2, 2019 * Mayne Pharma Group Limited (Mayne Pharma or Company) (ASX: MYX) has signed a 20‑year exclusive supply and license agreement with Mithra Pharmaceuticals, SA (Mithra) to commercialise a novel oral contraceptive comprising Estetrol (E4), and drospirenone, (E4/...
2019-10-02 12:01
8766
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval
SHANGHAI, Sept. 30, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining and attracting talent...
2019-10-01 04:00
8359
Ascletis Announces Departure of Chief Financial Officer
HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...
2019-09-30 16:30
1478
Week's Top Stories
Most Reposted
Agoda Partners with Sands China to Boost Tourism
[Picked up by 316 media titles]
2024-09-05 11:00The Beach Grill Unveils Exciting New Dishes: Elevating The Beachfront Dining Experience
[Picked up by 297 media titles]
2024-09-05 11:21
povo2.0, Japan's favourite digital telco, achieves highest user engagement and customer satisfaction rates with Circles' SaaS technology
[Picked up by 294 media titles]
2024-09-06 10:00Armacell will take complete ownership of the successful aerogel joint venture, AJA, following an agreement with JIOS Aerogel
[Picked up by 285 media titles]
2024-09-02 14:00Shiperoo Pioneers Tech-led Retail Returns and Fulfilment with AUD 30 Million Investment in Robotic Automated Facilities in Australia and New Zealand
[Picked up by 276 media titles]
2024-09-04 09:12
Most Read
Shiperoo Pioneers Tech-led Retail Returns and Fulfilment with AUD 30 Million Investment in Robotic Automated Facilities in Australia and New Zealand
2024-09-04 09:12
8836
Agoda Partners with Sands China to Boost Tourism
2024-09-05 11:00
8397
The Beach Grill Unveils Exciting New Dishes: Elevating The Beachfront Dining Experience
2024-09-05 11:21
6557